Liverpool has taken a pioneering step by becoming the first city in the UK to introduce the BEAT Pharmacy initiative, a community-focused pilot aimed at enhancing early detection of heart failure and addressing health inequalities throughout the city. This program offers heart health assessments in a local setting, making vital testing more accessible to those who may be at risk.

This new initiative is part of the broader BEAT Heart Failure programme, a collaborative effort led by the University Hospitals of Liverpool Group and The Pumping Marvellous Foundation. It also involves partnerships with NHS Cheshire & Merseyside, the Liverpool Local Pharmacy Committee, and Liverpool City Council – Public Health. Together, these organizations aim to deliver rapid, community-based care to improve cardiovascular health outcomes.

The first BEAT Pharmacy opened on 26 March at Lower House Lane Pharmacy, where it provides point-of-care NTproBNP blood testing for individuals experiencing symptoms encompassed by the BEAT acronym: Breathlessness, feeling Exhausted, swollen Ankles, and recognizing it’s Time to get checked. This quick testing method facilitates earlier identification of suspected heart failure, accelerates referrals to specialist care, and shortens the time to diagnosis and treatment.

Dr Nick Hartshorne-Evans, CEO and Founder of The Pumping Marvellous Foundation, emphasized the importance of expanding access to testing, stating, “Expanding access to point-of-care testing is essential for individuals at risk of heart failure, particularly those with existing cardiovascular conditions. Community pharmacy represents a scalable, community-based solution, enabling a preventative approach that uses technology to support earlier diagnosis and more timely intervention.” Likewise, Professor Matt Ashton, Director of Public Health for Liverpool City Council, highlighted the initiative’s potential impact on health inequalities and patient outcomes, mentioning that the model will make a “real difference” by ensuring those most at risk receive timely preventative cardiovascular care closer to home.

Liverpool’s commitment to addressing health inequalities follows recommendations made two years ago in the Liverpool 2040 report, which called for coordinated action against preventable health issues. The role of community pharmacies has been recognized as essential because of their accessibility and embedded presence in neighbourhoods. Liverpool has already led in expanding pharmacy services, such as providing emergency contraception and offering blood pressure checks and vaccinations. Matthew Burgoyne, an IP Pharmacist and Pharmacy Partner at Lower House Pharmacy, expressed enthusiasm for the new service, sharing hopes that the BEAT Pharmacy pilot will pave the way for long-term, nationwide programs that maximize the potential of pharmacies in community health.

Supporting the initiative, Professor Sankaranarayanan, Consultant Cardiologist at UHLG, underscored the importance of pharmacists in cardiovascular care, noting that this patient-centred approach is vital for early detection not only of heart failure but also atrial fibrillation and hypertension. The BEAT Pharmacy initiative thus represents a significant advancement in Liverpool’s healthcare landscape, expanding the role of pharmacies in cardiovascular prevention and early diagnosis

Read the full article on Liverpool Express here: Read More